{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/EDIT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-08T11:25:53.899Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10654,"canonical_name":"Editas Medicine, Inc.","cik":"0001650664","uei":null,"lei":null,"duns":null,"ticker":"EDIT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":15},"count":15,"timeline":[{"ts":"2026-07-21","kind":"sec.form144","reporter":"Burkly Linda","title":"Officer","shares":5500,"usd_value":15840,"security_title":"Common Stock","approx_sale_date":"2026-07-27","accession_number":"0001650664-26-000074","importance":40.003168},{"ts":"2026-07-21","kind":"sec.filing","form_type":"144","title":"144 — Editas Medicine, Inc. — 2026-07-21","url_slug":"/sec/cik-0001650664/144/0001650664-26-000074","accession_number":"0001650664-26-000074","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Editas Medicine, Inc. — 2026-06-22","url_slug":"/sec/cik-0001650664/4/0001650664-26-000068","accession_number":"0001650664-26-000068","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Editas Medicine, Inc. — 2026-06-22","url_slug":"/sec/cik-0001650664/4/0001650664-26-000069","accession_number":"0001650664-26-000069","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Editas Medicine, Inc. — 2026-06-22","url_slug":"/sec/cik-0001650664/4/0001650664-26-000072","accession_number":"0001650664-26-000072","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Editas Medicine, Inc. — 2026-06-18","url_slug":"/sec/cik-0001650664/8-k/0001650664-26-000063","accession_number":"0001650664-26-000063","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Editas Medicine, Inc. — 2026-06-05","url_slug":"/sec/cik-0001650664/4/0001650664-26-000055","accession_number":"0001650664-26-000055","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Editas Medicine, Inc. — 2026-06-05","url_slug":"/sec/cik-0001650664/4/0001650664-26-000056","accession_number":"0001650664-26-000056","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — Editas Medicine, Inc. — 2026-06-05","url_slug":"/sec/cik-0001650664/4/0001650664-26-000057","accession_number":"0001650664-26-000057","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Editas Medicine, Inc. — 2026-06-03","url_slug":"/sec/cik-0001650664/schedule-13g/0001193125-26-255480","accession_number":"0001193125-26-255480","importance":55},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"O'Neill Gilmore Neil","title":"CEO","shares":15380,"price_per_share":2.7011,"usd_value":41543,"security_title":"Common Stock","importance":35.041542918},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Burkly Linda","title":"EVP, CHIEF SCIENTIFIC OFFICER","shares":731,"price_per_share":2.7011,"usd_value":1975,"security_title":"Common Stock","importance":35.0019745041},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Parison Amy","title":"SVP, Chief Financial Officer","shares":464,"price_per_share":2.701,"usd_value":1253,"security_title":"Common Stock","importance":35.001253264},{"ts":"2026-06-02","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Editas Medicine, Inc. — 2026-06-02","url_slug":"/sec/cik-0001650664/schedule-13g/0001831942-26-000027","accession_number":"0001831942-26-000027","importance":55},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Editas Medicine, Inc. — 2026-05-14","url_slug":"/sec/cik-0001650664/8-k/0001650664-26-000049","accession_number":"0001650664-26-000049","importance":35}]}